Highlighting Exosome-Driven Therapeutic Mechanisms of Deramiocel, an Allogeneic Cardiac-Derived Cell Therapy
- Exploring recent update of deramiocel Phase 3 trial
- Reviewing direct evidence deramiocel exosome homing to skeletal muscle
- Understanding MOA of exosome on anti-fibrosis, anti-inflammatory and potential targeting mechanism